At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Benzoic acids
- Mechanism of Action Apoptosis stimulants; Caspase 9 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 Jun 2013 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 18 Apr 2002 No development reported - Preclinical for Cancer in USA (unspecified route)
- 13 Apr 2000 Preclinical development for Cancer in USA (Unknown route)